Creator/Principal investigator(s)
Anders Fridberger - Linköping University, Department of Clinical and Experimental Medicine, IKE
Description
Background: Otosclerosis is a disorder that impairs middle ear function, leading to conductive hearing loss. Surgical treatment results in large improvement of hearing at low sound frequencies, but high-frequency hearing often suffers. A likely reason for this is that inner ear sensory cells are damaged by surgical trauma and loud sounds generated during the operation. Animal studies have shown that antioxidants such as N-Acetylcysteine can protect the inner ear from noise, surgical trauma, and some ototoxic substances, but it is not known if this works in humans. This trial was performed to determine whether antioxidants improve surgical results at high frequencies.
Methods: We performed a randomized, double-blind and placebo-controlled parallel group clinical trial at three Swedish university clinics. Using block-stratified randomization, 156 adult patients undergoing stapedotomy were assigned to intravenous N-Acetylcysteine (150 mg/kg body weight) or matching placebo (1:1 ratio), starting one hour before surgery. The primary outcome was the hearing threshold at 6 and 8 kHz; secondary outco
Language
English
Research principal
Responsible department/unit
Department of Clinical and Experimental Medicine, IKE
Ethics Review
Stockholm - Ref. 2007/305-31
Unit of analysis
Population
Patients who had surgery for otosclerosis at Karolinska University Hospital in Solna and Huddinge, and at Uppsala University Hospital.
Study design
Double-blind randomised trial
Sampling procedure
Time period(s) investigated
2007-12-01 – 2013-04-30
Geographic spread
Geographic description: Stockholm, Uppsala
Research area
HEALTH
(CESSDA Topic Classification)
Medical and Health Sciences, Neurosciences
(The Swedish standard of fields of research 2011)
Keywords
hearing, hearing loss, ear diseases, antioxidants, otosclerosis, stapedotomy, prevention
Fridberger A. A randomised, double blind trial of N-acetylcysteine for hearing protection during stapes surgery. PLOS One 2014, In press.
If you have published anything based on these data, please notify us with a reference to your publication(s). If you are responsible for the catalogue entry, you can update the metadata/data description in DORIS.
Download data
Associated documentation
Description
The dataset contains 9 variables:
"id" is a number with range 1 - 145, unique for each patient.
"medicin" denotes the type of treatment given (possible values are "N-Acetylcysteine" or "Placebo").
"beta" denotes whether the steroid betametason was given before surgery.
"gender" is "f" for female patients and "m" for males.
"weight" is each patient's weight in kg.
"age" is the age (in years, at the time of surgery).
"freq" denotes the type of measurement performed. There are several possible valu
Version 1.0
https://doi.org/10.5878/002570
Citation
Download citation
Data format / data structure
Numeric
Creator/Principal investigator(s)
Anders Fridberger - Linköping University, Department of Clinical and Experimental Medicine, IKE
Time period(s) investigated
2007-12-01 – 2013-04-30
Variables
9
Number of individuals/objects
145